The brokerage industry regulator cited gaps in surveillance, customer due diligence, and red-flag escalation across the ...

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

The latest update is out from Aptose Biosciences ( (TSE:APS) ).

TRM Labs, the blockchain intelligence platform, announced partnership with Sphinx, a key player focused on AI agents for financial crime detection.

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...

The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. It affects the ability of your bone marrow to produce normal-functioning white blood cells (WBCs). The risk of this type of ...

Acute myeloid leukemia (AML) is a cancer that occurs in the blood and bone marrow. In its early stages, the symptoms of AML may resemble the flu, and you may have a fever and fatigue. Treatment for ...